News

Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature…
Read More...

Ivy Brain Tumor Center at Barrow Neurological Institute announced today a new collaboration with Vivace Therapeutics. The Ivy Brain Tumor Center, which employs a bold, early-phase…
Read More...

HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunomodulation, announced the submission of an Investigational New…
Read More...

Novartis announced that, at primary analysis, the Phase III ASCEMBL study met its primary endpoint of statistically significant superiority in major molecular response (MMR) rate at 24…
Read More...

MedGenome, a leading genomic diagnostics, research and data company based in Foster City, CA and Bangalore, India, announced that it has formed a strategic discovery collaboration…
Read More...

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, entered into a…
Read More...

ACADIA Pharmaceuticals Inc. announced the acquisition of CerSci Therapeutics, a clinical-stage biotechnology company with worldwide rights to a portfolio of novel compounds for…
Read More...

EpiVax, Inc. a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate,…
Read More...

HitGen Inc. announced that the company has achieved a milestone in their strategic collaboration with Almirall to develop a novel class of drugs. The licensed compounds were identified…
Read More...

AbbVie and Harvard University announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel…
Read More...

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology, a clinical-stage immunology…
Read More...

Catalent, Inc. announced that Catalent Cell & Gene Therapy will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19…
Read More...

PCI Pharma Services, a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, and portfolio company of Partners Group, announced today the signing of a…
Read More...

Bristol Myers Squibb and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic…
Read More...

Bio-Thera Solutions, Ltd. and BeiGene, Ltd. announced that the companies have executed a license, distribution, and supply agreement for China for Bio-Thera’s BAT1706, an…
Read More...

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce targeted polyclonal antibodies, announced the dosing of the…
Read More...

 Renalytix AI plc announced a collaboration with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases. The first stage in the…
Read More...

Sanofi and Principia Biopharma Inc. entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100  per share in cash, which…
Read More...

Boehringer Ingelheim announced that the first patient has enrolled in InPedILD, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and…
Read More...

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with…
Read More...